Status:

COMPLETED

Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia

Lead Sponsor:

Melbourne Health

Conditions:

Atrial Fibrillation

Atrial Flutter

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to investigate whether fish oils may be of benefit to patients with certain heart rhythm disturbances called atrial fibrillation and atrial flutter. Atrial fibrillation a...

Eligibility Criteria

Inclusion

  • Chronic atrial flutter requiring radiofrequency ablation.
  • Chronic atrial fibrillation requiring internal cardioversion.

Exclusion

  • Sinus rhythm.
  • Pregnancy.
  • Patients \> 80 years and \< 18 years of age

Key Trial Info

Start Date :

September 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2013

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00232232

Start Date

September 1 2003

End Date

November 1 2013

Last Update

May 12 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Melbourne Hospital

Melbourne, Victoria, Australia, 3050